HCG Partners Accenture to Personalize Cancer Care with AI

Healthcare Global Enterprises is developing algorithms that analyze clinical and genomic data to classify patients for more personalized cancer treatment, founder BS Ajaikumar said. The company partnered with Accenture to enhance its AI research capabilities. HCG aims to improve treatment outcomes by using patient data and artificial intelligence to guide clinical decisions. The partnership gives HCG access to Accenture's AI expertise and technology infrastructure. Ajaikumar said the initiative is part of a broader push to integrate data-driven approaches into oncology care. The company's ACN stock page partner brings experience in healthcare analytics and machine learning.